Comparing Adductor Canal Block and Adductor Canal Block-Local Infiltration Analgesia for Post-operative Pain Management
Comparison of the Effectiveness of Adductor Canal Block Versus Combination of Adductor Canal Block and Local Infiltration Analgesia: A Randomized Controlled Trial of the Effect on Postoperative Analgesia and Motor Power
1 other identifier
interventional
100
0 countries
N/A
Brief Summary
Anterior cruciate ligament (ACL) reconstruction is one of the most commonly performed surgeries amongst young orthopedic surgery patients. Optimal post-operative pain control helps to reduce the opioid burden and to improve the patient's experience. Regional anesthesia, such as the femoral nerve block (FNB) and adductor canal block (ACB), are commonly used for post-operative pain control after surgery. The ACB has replaced the FNB. This is because the ACB targets the femoral nerve, while avoiding the numbing effects on quadricep muscle strength that make it difficult to move the leg. Another form of pain control is local infiltration anesthesia (LIA), which directly blocks pain in the knee. Similar to the ACB, it avoids the numbing effects on the quadricep muscle.This can help improve patient safety and experience by reducing risks of falls and allowing the patient to move earlier. This can also be associated with decreased time in the hospital and decreased costs. Technically, it is less complex and can be done the shorter period of time. The purpose of this study is to refine the pain management technique following anterior cruciate ligament surgery. More specifically, the aim of this study is to evaluate the effects of LIA alone, and a LIA-ACB combination on post-operative pain and thigh muscle strength.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2021
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 19, 2020
CompletedFirst Posted
Study publicly available on registry
January 22, 2021
CompletedStudy Start
First participant enrolled
February 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2021
CompletedJanuary 22, 2021
January 1, 2021
6 months
August 19, 2020
January 20, 2021
Conditions
Outcome Measures
Primary Outcomes (2)
Oral morphine equivalent consumption
Cumulative oral morphine equivalent consumption over 24 hours post-op
Up to 24-hours after surgery
Quadriceps motor strength
Percent decrease in quadriceps motor strength at 30 minutes following anesthesia compared to baseline
Pre-op, 30 minutes post-anesthesia
Secondary Outcomes (6)
inta-operative opioid consumption
during surgery
Oral morphine equivalent consumption in PACU
PACU admission to PACU discharge (approximately 4 hours)
Post-operative Pain
Up to 24 hours post-operative
Quality of Recovery
At 24 hours post-operative
Time in hospital
From hospital admission to hospital discharge (approximately 12 hours)
- +1 more secondary outcomes
Study Arms (2)
Local Infiltration Anesthetic
EXPERIMENTALThis group of patients will receive the local infiltration anesthetic only.
Local Infiltration Anesthetic + Adductor Canal Block
EXPERIMENTALThis group of patients will receive the local infiltration anesthetic and adductor canal block combination.
Interventions
For the local infiltration anesthetic, patients will receive 20 cc of 0.5% ropivacaine, by intra-articular injection performed by the surgeon. The injection is done at the end of the surgical procedure, after suturing the incision.
For the local infiltration anesthetic, patients will receive 20 cc of 0.25% ropivacaine, by intra-articular injection performed by the surgeon. The injection is done at the end of the surgical procedure, after suturing the incision. For the adductor canal block, patients will receive 20 cc of 0.25% ropivicaine, through injection performed by the anesthesiologist. The injection is done under the sartorius muscle, in mid-thigh, using ultrasound guidance.
Eligibility Criteria
You may qualify if:
- English speaking or any other language with possibility of adequate translation
- ASA I-III patients
- Age 18-50
- BMI ≤ 38 kg/m2
You may not qualify if:
- Refusal or inability to provide informed consent
- Any contraindication to regional anesthesia including coagulopathy or bleeding diathesis,
- Allergy to local anesthetics, or infection at the site of the block
- History of long-term opioid intake (more than 3 months use) or chronic pain disorder (more than 3 months)
- History of preexisting neuropathy in the operative leg
- Revision of ACL repair
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 19, 2020
First Posted
January 22, 2021
Study Start
February 1, 2021
Primary Completion
August 1, 2021
Study Completion
November 1, 2021
Last Updated
January 22, 2021
Record last verified: 2021-01